Searchable abstracts of presentations at key conferences in endocrinology

ea0003p248 | Steroids | BES2002

The relationship between smoking, statin therapy and testosterone in men with coronary artery disease

Morris P , Pugh P , Hall J , Channer K , Jones T

BACKGROUND: We have previously shown that men with coronary artery disease (CAD) have lower serum bioavailable testosterone levels than men with normal coronary arteries and this may have detrimental effects in coronary disease. It has been suggested that low androgen levels in men with CAD could be accounted for by the high prevalence of statin therapy and other factors such as smoking. We investigated the effects of statin therapy and smoking on testosterone in men with CAD....

ea0003p249 | Steroids | BES2002

Androgens and diabetes mellitus in men with coronary artery disease

Morris P , Pugh P , Roberts S , Channer K , Jones T

BACKGROUND: Previous work has demonstrated a relationship between impaired carbohydrate metabolism and low serum levels of androgens in men. Men with diabetes have lower testosterone levels, and administration of physiological doses of testosterone improves glucose tolerance in these men. Men with coronary artery disease (CAD) have lower androgen levels than men with normal coronary arteries. We studied the relationship between testosterone, glucose, hypertension and DM in a p...

ea0055wh1 | Workshop H: Miscellaneous endocrine and metabolic disorders | SFEEU2018

A daughter’s diagnosis

Manohar Rao Balmuri Laxmi , Morris Lauren , Mumby Clare , Beynon Jennifer , Issa Basil

Case: An 89 year old gentleman was admitted to hospital following a collapse at home. His capillary blood glucose was found to be 1.4 mmol/l by the paramedics. The patient had experienced multiple collapses at home in the preceding 2 weeks. Each time, he had been found to be hypoglycaemic but treated and discharged from A&E. He complained of reduced appetite, weight loss and change in bowel habit. The patient’s past medical history included a large fibroma of the left...

ea0086p52 | Metabolism, Obesity and Diabetes | SFEBES2022

Nrf2 activator Sulforaphane attenuates maternal adiposity and hepatic steatosis

Psefteli Paraskevi-Maria , Balagamage Alokya , Morris Jessica , Taylor Paul , Mann Giovanni , Chapple Sarah

Intro/Aims: Maternal obesity is a major risk factor for the development of first onset of diabetes in pregnancy, also known as gestational diabetes mellitus (GDM). Recent studies also indicate that non-alcoholic fatty liver disease (NAFLD) is an independent predictor of GDM. Sulforaphane (SFN) is a well-known dietary activator of the redox-sensitive transcription factor Nrf2, with reported anti-adipogenic and NAFLD ameliorating effects in non-pregnant obese rodent models. In t...

ea0086p55 | Metabolism, Obesity and Diabetes | SFEBES2022

Effect of sulforaphane, an activator of the Nrf2 antioxidant defence pathway, on maternal adiposity in a model of diet-induced insulin resistant pregnancy

Balagamage Alokya , Psefteli Paraskevi-Maria , Morris Jessica , Taylor Paul , Mann Giovanni , Chapple Sarah

The incidence of maternal obese and/or gestational diabetic (GDM) pregnancy are increasing globally, with ~10-20% of mothers classified as obese and/or GDM within the U.K. Both obese and GDM pregnancy are associated with increased risk of cardiometabolic disease, with mothers and their children at greater risk of developing later-life Type 2 diabetes, obesity and/or cardiovascular disease. Higher adiposity in pregnancy leads to increased inflammation, which may be countered by...

ea0065p102 | Bone and calcium | SFEBES2019

Parathyroidectomy outcomes for primary hyperparathyroidism over a 2 year period at East Sussex Hospitals Trust

Lewis-Morris Timothy , Chahal Sukhdeep , Phillips Jennifer , Kirkland Paul , Kumar Sathis

Introduction: An audit of outcomes and indications for parathyroidectomy was conducted from April 2016 to April 2018 for all patients had primary hyperparathyroidism at East Sussex Hospitals Trust.Methods: Clinical notes, pathology results and radiology results were accessed to compile the dataset. Indications for surgery were based on the National Institute of Health criteria for parathyroidectomy in hyperparathyroidism from 2013....

ea0065p171 | Metabolism and Obesity | SFEBES2019

5β-reductase (AKR1D1) isoforms differentially regulate natural and synthetic glucocorticoid clearance and glucocorticoid receptor activation in vitro

Appanna Nathan , Arvaniti Anastasia , Gangitano Elena , Morris Karen , George Sherly , Keevil Brian , Tomlinson Jeremy , Nikolaou Nikolaos

Metabolic syndrome and its hepatic manifestation, non-alcoholic fatty liver disease (NAFLD), are increasing in prevalence. Steroid hormones are established regulators of metabolic phenotype. 5β-reductase (AKR1D1) is highly expressed in human liver, inactivating steroid hormones, including glucocorticoids and androgens. The human AKR1D1 gene contains 9 exons; six splice variants have been identified and three lead to functional protein isoforms (AKR1D1-001, -0...

ea0062oc7 | Oral Communications | EU2019

An aldosterone crisis

Tufton Nicola , Rathore Ali , Matson Matthew , Hameeduddin Ayesha , Berney Daniel , Brown Morris , Akker Scott

Case history: A 26 year-old lady was admitted directly from the endocrine clinic with severe hypertension (BP 180/130 mmHg) and bilateral papilloedema. Six weeks prior to admission she had undergone resection of a 24 cm right upper quadrant lesion that was pre-operatively felt to be of hepatic origin. She was normotensive pre-operatively. Histology confirmed this to be an adrenal phaeochromocytoma with deficient SDH immunostaining. Pre-operative biochemical assessment had not ...

ea0062p29 | Poster Presentations | EU2019

Normotensive primary hyperaldosteronism as a prelude to atrial fibrillation: potentially curable by endoscopic radiofrequency ablation?

Wu Xilin , Ney Alexander , Cheow Heok , Drake William , Pereira Stephen P , Brown Morris

Case History: In 2011, an asymptomatic 63-year-old professor was found to have isolated hypokalemia. He was normotensive and his only past medical history was hypercholesterolaemia. Investigations were suggestive of Primary Hyperaldosteronism (PHA): aldosterone 1055 pmol/L, renin mass 10 mU/L, Na+137 mmol/L, K+3.2 mmol/L, bicarbonate 31 mmol/L. A CT scan was reported as normal, but a 12mm nodule was subsequently noted contiguous with the left adrenal. A m...

ea0044p210 | Reproduction | SFEBES2016

Safety and tolerability of inducing completion of puberty with IM testosterone over 1 year in older men with congenital hypogonadism and absent puberty

Pazderska Agniezska , Artham Satish , Miller Margaret , Morris Margaret , Ball Steve , Quinton Richard

Background: Guidance on pubertal-induction in hypogonadal adult men is sparse. For adolescent boys, in whom delay is usually constitutional, treatment is typically initiated with pulsed low-dose IM testosterone (T); the dose being progressively increased if/when it becomes clear that endogenous gonadotrophin secretion is not being initiated. In teenagers with organic hypogonadism, the aims are to recapitulate the normal tempo of puberty over 2–3 years and optimise linear ...